OP-1690
OP-1690 is a complete estrogen receptor (ERα) antagonist (CERAN), with pIC50 values of 7.5 and 7.9 in alkaline phosphatase (AP) activity assay and TR-FRET assay, respectively. OP-1690 modulates receptor function by inducing ERα tetramerization, effectively induces ERα degradation, inhibits target gene transcription, but exhibits low antiproliferative potency. OP-1690 can be used for breast cancer research.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C31H35ClF2N2O2
- 分子量:541.07
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
IC50 & Target
[1]|
ERα 7.5 (pIC50) |
体外実験
OP-1690 (7 d) inhibits the proliferation of MCF7 and CAMA-1 cells with pIC50 values of 6 and 5.9, respectively, which are lower than those of Fulvestrant (HY-13636) and RAD1901 (HY-19822).
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Parmacokinetics
化学情報
-
分子量 541.07
-
分子式 C31H35ClF2N2O2
-
SMILES
FC1=CC=CC=C1C2(CCCC2)CN(CC3=CC=CC(O)=C3Cl)C4=CC=C(OC5CN(CCCF)C5)C=C4
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)